Reporting perioperative complications of radical cystectomy: the influence of using standard methodology based on ICARUS and EAU quality criteria

[1]  S. Shariat,et al.  Impact of the controlling nutritional status (CONUT) score on perioperative morbidity and oncological outcomes in patients with bladder cancer treated with radical cystectomy. , 2022, Urologic oncology.

[2]  F. Montorsi,et al.  Neoadjuvant chemotherapy does not increase peri-operative morbidity following radical cystectomy , 2022, World Journal of Urology.

[3]  Lili Mi,et al.  Prognosis of hepatocellular carcinoma and its association with immune cells using systemic inflammatory response index. , 2022, Future oncology.

[4]  M. Michalak,et al.  Neutrophil Counts, Neutrophil-to-Lymphocyte Ratio, and Systemic Inflammatory Response Index (SIRI) Predict Mortality after Off-Pump Coronary Artery Bypass Surgery , 2022, Cells.

[5]  Cong Jiang,et al.  The Pretreatment Systemic Inflammation Response Index as a Useful Prognostic Factor is Better Than Lymphocyte to Monocyte Ratio in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. , 2022, Clinical breast cancer.

[6]  F. Saad,et al.  Effect of Neoadjuvant Chemotherapy on Complications, in-Hospital Mortality, Length of Stay and Total Hospital Costs in Bladder Cancer Patients Undergoing Radical Cystectomy , 2022, Cancers.

[7]  J. B. Jensen,et al.  Prospective versus retrospective recordings of comorbidities and complications in bladder cancer patients undergoing radical cystectomy – a randomized controlled trial , 2021, Scandinavian journal of urology.

[8]  Tianyuan Xu,et al.  Combination of Total Psoas Index and Albumin–Globulin Score for the Prognosis Prediction of Bladder Cancer Patients After Radical Cystectomy: A Population-Based Study , 2021, Frontiers in Oncology.

[9]  C. Liang,et al.  Prognostic Value of the Systemic Inflammatory Response Index in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Population-Based Study , 2021, Frontiers in Oncology.

[10]  Jarosław Jaskulski,et al.  The Comprehensive Complication Index. Proposed modification to improve estimates of perioperative morbidity after radical cystectomy. A pilot study , 2021, Central European journal of urology.

[11]  Dong-lin Hao,et al.  Systemic inflammatory response index as an independent risk factor for ischemic stroke in patients with rheumatoid arthritis: a retrospective study based on propensity score matching , 2021, Clinical Rheumatology.

[12]  Yonghua Lei,et al.  Prognostic values of preoperative neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and lymphocyte- to-monocyte ratio for patients with muscle- invasive bladder cancer undergoing radical cystectomy. , 2021, Archivos espanoles de urologia.

[13]  H. Kehlet,et al.  Short-term morbidity and mortality following radical cystectomy: a systematic review , 2021, BMJ Open.

[14]  Yong-Beom Park,et al.  Systemic inflammation response index predicts all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis , 2021, International Urology and Nephrology.

[15]  J. Breyer,et al.  The comprehensive complication index is associated with a significant increase in complication severity between 30 and 90 days after radical cystectomy for bladder cancer. , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[16]  M. Walach,et al.  The comprehensive complication index (CCI): proposal of a new reporting standard for complications in major urological surgery , 2020, World Journal of Urology.

[17]  L. Mordasini,et al.  The impact of preoperative nutritional status on post-surgical complication and mortality rates in patients undergoing radical cystectomy for bladder cancer: a systematic review of the literature , 2020, World Journal of Urology.

[18]  J. Witjes,et al.  European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. , 2020, European urology.

[19]  J. Witjes,et al.  The Importance of Hospital and Surgeon Volume as Major Determinants of Morbidity and Mortality After Radical Cystectomy for Bladder Cancer: A Systematic Review and Recommendations by the European Association of Urology Muscle-invasive and Metastatic Bladder Cancer Guideline Panel. , 2019, European urology oncology.

[20]  J. Pečánka,et al.  Intraoperative Adverse Incident Classification (EAUiaiC) by the European Association of Urology ad hoc Complications Guidelines Panel. , 2019, European urology.

[21]  P. Malmström,et al.  No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study , 2019, World Journal of Urology.

[22]  Xiaozhou He,et al.  Systemic inflammation response index predicts prognosis in patients with clear cell renal cell carcinoma: a propensity score-matched analysis , 2019, Cancer management and research.

[23]  Xiaoping Zhou,et al.  Pre-treatment prognostic nutritional index may serve as a potential biomarker in urinary cancers: a systematic review and meta-analysis , 2018, Cancer Cell International.

[24]  Tetsuya Shindo,et al.  Complications within 90 days after radical cystectomy for bladder cancer: results of a multicenter prospective study in Japan , 2018, International Journal of Clinical Oncology.

[25]  K. Hirakawa,et al.  The peripheral monocyte count is associated with the density of tumor-associated macrophages in the tumor microenvironment of colorectal cancer: a retrospective study , 2017, BMC Cancer.

[26]  Hong-zhao Li,et al.  Prognostic value of a systemic inflammatory response index in metastatic renal cell carcinoma and construction of a predictive model , 2016, Oncotarget.

[27]  Zhen Chen,et al.  A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy , 2016, Cancer.

[28]  F. Montorsi,et al.  The effect of neoadjuvant chemotherapy on perioperative outcomes in patients who have bladder cancer treated with radical cystectomy: a population-based study. , 2014, European urology.

[29]  E. Wallen,et al.  Neoadjuvant chemotherapy for bladder cancer does not increase risk of perioperative morbidity , 2014, BJU international.

[30]  Will Liao,et al.  The cellular and molecular origin of tumor-associated macrophages , 2014, Science.

[31]  M. Remzi,et al.  Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU guidelines panel assessment and recommendations. , 2012, European urology.

[32]  A. Vickers,et al.  Age‐adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer , 2008, Cancer.

[33]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[34]  M. Srougi,et al.  Complications in radical cystectomy performed at a teaching hospital. , 2002, International braz j urol : official journal of the Brazilian Society of Urology.

[35]  Robert C. G. Martin,et al.  Quality of Complication Reporting in the Surgical Literature , 2002, Annals of surgery.

[36]  Steven A. Rosenberg,et al.  Progress in human tumour immunology and immunotherapy , 2001, Nature.

[37]  P. Gild,et al.  Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. , 2019, European urology.

[38]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..